Otitis externa historical perspective: Difference between revisions
No edit summary |
m (Bot: Removing from Primary care) |
||
(11 intermediate revisions by 4 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Otitis externa}} | {{Otitis externa}} | ||
{{CMG}} {{AE}} {{LRO}} | {{CMG}}; {{AE}} {{LRO}}; {{TarekNafee}} | ||
==Overview== | ==Overview== | ||
Otitis externa was first identified in 1873 by Adam Politzer, classified and recorded as one of the otological pathologies codified in his otology clinic in Austria. [[Burow's solution]], a therapeutic application of aqueous [[aluminium acetate]], was invented by Karl August Burow in the mid-19th century. [[Antibiotic]] therapy for chronic otitis externa treatment emerged with the invention of mass production of [[penicillin]] in 1940 by Alexander Fleming, Howard Florey, and Ernst Chain. [[Corticosteroid]] therapy to relieve pain and itching from otitis externa emerged with the discovery of the [[glucocorticoid]] [[dexamethasone]] in 1957. The current therapy of "ear drops," or topical application of [[antibiotics]], began to be administered to otitis externa patients in 1987 after the discovery of [[ciprofloxacin]], a [[fluoroquinolone]]-class antibiotic. | |||
== | ==Historical Perspective== | ||
*German physicians Hermann Schwartze, Anton von Troltsch, and Adam Politzer advanced the discourse of clinicial study of otitis externa by publishing the first journal dedicated to ear pathology and treatment in 1865.<ref name="pmid25992009">{{cite journal |vauthors=Bento RF, Fonseca AC |title=A brief history of mastoidectomy |journal=Int Arch Otorhinolaryngol |volume=17 |issue=2 |pages=168–78 |year=2013 |pmid=25992009 |pmc=4423283 |doi=10.7162/S1809-97772013000200009 |url=}}</ref> | *German physicians Hermann Schwartze, Anton von Troltsch, and Adam Politzer advanced the discourse of clinicial study of otitis externa by publishing the first journal dedicated to ear pathology and treatment in 1865.<ref name="pmid25992009">{{cite journal |vauthors=Bento RF, Fonseca AC |title=A brief history of mastoidectomy |journal=Int Arch Otorhinolaryngol |volume=17 |issue=2 |pages=168–78 |year=2013 |pmid=25992009 |pmc=4423283 |doi=10.7162/S1809-97772013000200009 |url=}}</ref> | ||
*Adam Politzer founded the first otology clinic in 1873 in Austria, beginning the codification and standardization of ear disease treatment, such as otitis externa. | *Adam Politzer founded the first otology clinic in 1873 in Austria, beginning the codification and standardization of ear disease treatment, such as otitis externa. | ||
Line 13: | Line 12: | ||
*[[Antibiotic]] therapy for chronic otitis externa treatment emerged with the invention of mass production of [[penicillin]] in 1940 by Alexander Fleming, Howard Florey, and Ernst Chain.<ref name="pmid11624973">{{cite journal |vauthors=Diamant H, Hultcrantz M |title=[Glimpses from the history of otitis media] |language=Swedish |journal=Nord Medicinhist Arsb |volume= |issue= |pages=189–95 |year=1996 |pmid=11624973 |doi= |url=}}</ref> | *[[Antibiotic]] therapy for chronic otitis externa treatment emerged with the invention of mass production of [[penicillin]] in 1940 by Alexander Fleming, Howard Florey, and Ernst Chain.<ref name="pmid11624973">{{cite journal |vauthors=Diamant H, Hultcrantz M |title=[Glimpses from the history of otitis media] |language=Swedish |journal=Nord Medicinhist Arsb |volume= |issue= |pages=189–95 |year=1996 |pmid=11624973 |doi= |url=}}</ref> | ||
**This was the first instance of the modern use of antibiotic therapy for otitis externa treatment. | **This was the first instance of the modern use of antibiotic therapy for otitis externa treatment. | ||
*The "tektite solution" therapy of 15% tannic acid, 15% acetic acid, and 50% isopropanol or ethanol, emerged in 1969 in response to high incidence of otitis externa in biologists involved in the Tektite I diving mission.<ref name ="Tektite">{{Citation | author1=Shilling, Charles W. (Charles Wesley) | author2=Werts, Margaret F, (joint author.) | title=An annotated bibliography on diving and submarine medicine | publication-date=1971 | publisher=Gordon and Breach | isbn=978-0-677-03910-7 }}</ref> | *[[Corticosteroid]] therapy to relieve pain and itching from otitis externa emerged with the discovery of the [[glucocorticoid]] [[dexamethasone]] in 1957.<ref name="RankovicBingham2012">{{cite journal|last1=Rankovic|first1=Zoran|last2=Bingham|first2=Matilda|last3=Nestler|first3=Eric J|last4=Hargreaves|first4=Richard|year=2012|issn=2041-3211|doi=10.1039/9781849734943}}</ref> | ||
*The "tektite solution" therapy of 15% [[tannic acid]], 15% [[acetic acid]], and 50% [[isopropanol]] or [[ethanol]], emerged in 1969 in response to high incidence of otitis externa in biologists involved in the Tektite I diving mission.<ref name ="Tektite">{{Citation | author1=Shilling, Charles W. (Charles Wesley) | author2=Werts, Margaret F, (joint author.) | title=An annotated bibliography on diving and submarine medicine | publication-date=1971 | publisher=Gordon and Breach | isbn=978-0-677-03910-7 }}</ref> | |||
*The current therapy of "ear drops," or topical application of [[antibiotics]], began to be administered to otitis externa patients in 1987 after the discovery of [[Ciprofloxacin]], a [[fluoroquinolone]]-class antibiotic.<ref name="urlOrange Book: Approved Drug Products with Therapeutic Equivalence Evaluations">{{cite web |url=http://www.accessdata.fda.gov/scripts/cder/ob/docs/obdetail.cfm?Appl_No=019537&TABLE1=OB_Rx |title=Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations |format= |work= |accessdate=}}</ref><ref name="pmid21845055">{{cite journal |vauthors=Mösges R, Nematian-Samani M, Eichel A |title=Treatment of acute otitis externa with ciprofloxacin otic 0.2% antibiotic ear solution |journal=Ther Clin Risk Manag |volume=7 |issue= |pages=325–36 |year=2011 |pmid=21845055 |pmc=3150478 |doi=10.2147/TCRM.S6769 |url=}}</ref> | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:FinalQCRequired]] | |||
[[Category:Emergency mdicine]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
[[Category:Otolaryngology]] | [[Category:Otolaryngology]] | ||
[[Category:Pediatrics]] | [[Category:Pediatrics]] | ||
[[Category:Immunology]] | |||
Latest revision as of 23:29, 29 July 2020
Otitis externa Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Otitis externa historical perspective On the Web |
American Roentgen Ray Society Images of Otitis externa historical perspective |
Risk calculators and risk factors for Otitis externa historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Luke Rusowicz-Orazem, B.S.; Tarek Nafee, M.D. [2]
Overview
Otitis externa was first identified in 1873 by Adam Politzer, classified and recorded as one of the otological pathologies codified in his otology clinic in Austria. Burow's solution, a therapeutic application of aqueous aluminium acetate, was invented by Karl August Burow in the mid-19th century. Antibiotic therapy for chronic otitis externa treatment emerged with the invention of mass production of penicillin in 1940 by Alexander Fleming, Howard Florey, and Ernst Chain. Corticosteroid therapy to relieve pain and itching from otitis externa emerged with the discovery of the glucocorticoid dexamethasone in 1957. The current therapy of "ear drops," or topical application of antibiotics, began to be administered to otitis externa patients in 1987 after the discovery of ciprofloxacin, a fluoroquinolone-class antibiotic.
Historical Perspective
- German physicians Hermann Schwartze, Anton von Troltsch, and Adam Politzer advanced the discourse of clinicial study of otitis externa by publishing the first journal dedicated to ear pathology and treatment in 1865.[1]
- Adam Politzer founded the first otology clinic in 1873 in Austria, beginning the codification and standardization of ear disease treatment, such as otitis externa.
- Burow's solution, a therapeutic application of aqueous aluminium acetate, was invented by Karl August Burow in the mid-19th century that is still used presently as a topical remedy for otitis externa.[2]
- Antibiotic therapy for chronic otitis externa treatment emerged with the invention of mass production of penicillin in 1940 by Alexander Fleming, Howard Florey, and Ernst Chain.[3]
- This was the first instance of the modern use of antibiotic therapy for otitis externa treatment.
- Corticosteroid therapy to relieve pain and itching from otitis externa emerged with the discovery of the glucocorticoid dexamethasone in 1957.[4]
- The "tektite solution" therapy of 15% tannic acid, 15% acetic acid, and 50% isopropanol or ethanol, emerged in 1969 in response to high incidence of otitis externa in biologists involved in the Tektite I diving mission.[5]
- The current therapy of "ear drops," or topical application of antibiotics, began to be administered to otitis externa patients in 1987 after the discovery of Ciprofloxacin, a fluoroquinolone-class antibiotic.[6][7]
References
- ↑ Bento RF, Fonseca AC (2013). "A brief history of mastoidectomy". Int Arch Otorhinolaryngol. 17 (2): 168–78. doi:10.7162/S1809-97772013000200009. PMC 4423283. PMID 25992009.
- ↑ REES CW (1949). "Otitis externa". Calif Med. 70 (4): 288–91. PMC 1643794. PMID 18116233.
- ↑ Diamant H, Hultcrantz M (1996). "[Glimpses from the history of otitis media]". Nord Medicinhist Arsb (in Swedish): 189–95. PMID 11624973.
- ↑ Rankovic, Zoran; Bingham, Matilda; Nestler, Eric J; Hargreaves, Richard (2012). doi:10.1039/9781849734943. ISSN 2041-3211. Missing or empty
|title=
(help) - ↑ Shilling, Charles W. (Charles Wesley); Werts, Margaret F, (joint author.) (1971), An annotated bibliography on diving and submarine medicine, Gordon and Breach, ISBN 978-0-677-03910-7
- ↑ "Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations".
- ↑ Mösges R, Nematian-Samani M, Eichel A (2011). "Treatment of acute otitis externa with ciprofloxacin otic 0.2% antibiotic ear solution". Ther Clin Risk Manag. 7: 325–36. doi:10.2147/TCRM.S6769. PMC 3150478. PMID 21845055.